Polyamines & Cancer: How the Same Molecules Impact Aging vs. Tumor Growth

The quest for healthy aging has focused increasing attention on spermidine, a naturally occurring compound found in foods like wheat germ, soybeans, and aged cheese. Often touted for its ability to stimulate autophagy – the body’s process for clearing out damaged cells – spermidine has gained popularity as a supplement. However, a latest study from Tokyo University of Science is adding a layer of complexity to this narrative, revealing that spermidine’s effects can diverge dramatically depending on the cellular environment, potentially fueling cancer growth in some cases. The research, published in the Journal of Biological Chemistry, highlights the critical role of specific protein interactions in mediating spermidine’s impact.

Polyamines: A Double-Edged Sword

Polyamines, including spermidine, are essential molecules involved in cell growth and specialization. They’ve been investigated for their potential to extend lifespan and improve healthspan, largely through their ability to enhance autophagy. This cellular “recycling” process removes damaged components, contributing to overall cellular health. The benefits of spermidine are thought to rely heavily on a protein called eukaryotic translation initiation factor 5A (eIF5A1). But scientists have long observed surprisingly high levels of polyamines in many aggressive cancers, creating a perplexing contradiction. How can a compound linked to longevity also be associated with tumor progression?

The key, researchers are discovering, lies in the nuanced interplay between spermidine and two closely related proteins: eIF5A1 and eIF5A2. While sharing 84% of their amino acid sequence, these proteins appear to drive remarkably different outcomes. EIF5A1 is associated with healthy aging and mitochondrial function, while eIF5A2 has been linked to cancer development. Understanding why these nearly identical proteins behave so differently has been a central challenge for researchers.

Unraveling the Metabolic Shift in Cancer Cells

The team led by Associate Professor Kyohei Higashi used advanced molecular and proteomic methods to investigate how polyamines affect protein production and metabolism in human cancer cell lines. They manipulated polyamine levels – reducing them with a drug and then restoring them with spermidine – to directly observe the impact on cancer cells. Analyzing over 6,700 proteins, they found that polyamines primarily boost glycolysis, a rapid energy-producing process favored by cancer cells, rather than supporting mitochondrial respiration, which is crucial for healthy aging.

This finding aligns with the well-established observation that cancer cells often alter their metabolism, relying heavily on aerobic glycolysis – a process known as the Warburg effect – to rapidly generate energy. Spermidine’s role as an autophagy inducer has been previously documented, but this study clarifies how that induction can be hijacked by cancer cells to support their growth.

eIF5A1 and eIF5A2: Distinct Roles in Cellular Processes

The research revealed that polyamines increase levels of eIF5A2 and several ribosomal proteins – RPS 27A, RPL36AL, and RPL22L1 – all of which are associated with cancer severity. A direct comparison of eIF5A1 and eIF5A2 revealed a critical distinction: “The biological activity of polyamines via eIF5A differs between normal and cancer tissues,” explains Dr. Higashi. “In normal tissues, eIF5A1, activated by polyamines, activates mitochondria via autophagy, whereas in cancer tissues, eIF5A2, whose synthesis is promoted by polyamines, controls gene expression at the translational level to facilitate the proliferation of cancer cells.”

Essentially, polyamines act as a switch, directing their effects based on which protein they influence. In healthy cells, they support cellular maintenance and energy production. In cancer cells, they promote rapid growth and proliferation. This duality helps explain why research on polyamines has yielded such conflicting results.

How Polyamines Amplify eIF5A2 Production

The study further uncovered the mechanism by which polyamines elevate eIF5A2 levels. Normally, the production of the eIF5A2 protein is kept in check by a small regulatory RNA molecule called miR-6514-5p. The researchers found that polyamines disrupt this natural regulatory process, allowing eIF5A2 to be produced in greater quantities. They also demonstrated that eIF5A2 controls a different set of proteins than eIF5A1, reinforcing the idea that these two similar proteins perform distinct functions.

Implications for Cancer Therapy and Supplement Use

These findings have significant implications for both cancer treatment and the use of polyamine supplements. The research underscores the importance of biological context. While polyamines may offer anti-aging benefits in healthy tissues through eIF5A1, they can stimulate tumor growth in cancerous tissues through eIF5A2. This dual behavior explains the challenges researchers have faced in interpreting polyamine’s role in medical research.

The study also identifies eIF5A2 as a potential therapeutic target. “Our findings reveal an important role for eIF5A2, regulated by polyamines and miR-6514-5p, in cancer cell proliferation, suggesting that the interaction between eIF5A2 and ribosomes, which regulates cancer progression, is a selective target for cancer treatment,” Dr. Higashi notes. Targeting eIF5A2 specifically could potentially slow cancer growth without disrupting the beneficial effects linked to eIF5A1.

This research builds on previous work demonstrating spermidine’s impact on autophagy. A 2024 study in Nature Metabolism showed that spermidine is essential for fasting-mediated autophagy, a process linked to longevity and healthspan extension. However, the new findings from Tokyo University of Science add a crucial caveat: the benefits of spermidine may not be universal and could be context-dependent.

What Comes Next: Refining Therapeutic Strategies

Further research is needed to fully understand the complex interplay between polyamines, eIF5A1, and eIF5A2. Scientists are now focused on developing strategies to selectively target eIF5A2 in cancer cells, potentially through the development of drugs that disrupt the interaction between eIF5A2 and ribosomes. Ongoing investigations are also exploring the role of spermidine as an epigenetic regulator of autophagy in neurodegenerative disorders, highlighting the broad range of biological processes influenced by this versatile molecule. For individuals considering spermidine supplementation, these findings emphasize the importance of discussing potential risks and benefits with a qualified healthcare professional, particularly if they have a personal or family history of cancer.